MetaCap

Capstone Insider Trades

NASDAQ: CAPSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.44-0.145 (-9.15%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Capstone insider activity

Over the last 12 months, Capstone insiders reported 15 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows FELDMAN FREDRIC J (Director) reporting a transaction in 105,124 shares on Aug 7, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CAPS's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CAPS insider transactions

Capstone insider transactions
DateInsiderTypeSharesValueFiling
Aug 7, 2026Strout Gordon Lewis JrDirectorAward357,810—Form 4
Aug 7, 2026TOPOREK MICHAELDirectorAward1,094,647—Form 4
Aug 7, 2026HOWSE ELWOOD DDirectorAward105,124—Form 4
Aug 7, 2026SCHULTZ EDWARD CHRISTOPHERChief Financial OfficerAward310,310—Form 4
Aug 7, 2026Grotke Kevin AllanPresident & CEO of TotalStoneAward515,495—Form 4
Aug 7, 2026Lipman Matthew E.Chief Executive OfficerAward1,094,648—Form 4
Aug 7, 2026HOLLIMAN JOHN M IIIDirectorAward305,248—Form 4
Aug 7, 2026FELDMAN FREDRIC JDirectorAward105,124—Form 4
Mar 30, 2026SCHULTZ EDWARD CHRISTOPHERChief Financial OfficerAward190,000—Form 4
Mar 30, 2026Lipman Matthew E.Chief Executive OfficerAward356,250—Form 4
Mar 30, 2026TOPOREK MICHAELDirectorAward356,250—Form 4
Mar 30, 2026Strout Gordon Lewis JrDirectorAward142,500—Form 4
Mar 30, 2026HOWSE ELWOOD DDirectorAward95,000—Form 4
Mar 30, 2026HOLLIMAN JOHN M IIIDirectorAward95,000—Form 4
Mar 30, 2026FELDMAN FREDRIC JDirectorAward95,000—Form 4
Mar 7, 2025Lipman Matthew E.Chief Executive OfficerBuy41,750$167.00KForm 4
Mar 7, 2025TOPOREK MICHAELDirectorBuy41,750$167.00KForm 4
Mar 7, 2025Strout Gordon Lewis JrDirectorBuy41,500$166.00KForm 4
Mar 7, 2025Strout Gordon Lewis JrDirectorother822,128—Form 4
Dec 21, 2018SUBIN NEIL S10% OwnerBuy103,000$5.36KForm 4
Dec 21, 2018SUBIN NEIL S10% OwnerSale206,000$10.71KForm 4
Oct 5, 2017MILLER LLOYD I III10% OwnerSale100,000$6.00KForm 4
Jul 14, 2017BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of ResponsesSale105,713$6.34KForm 4
Jul 14, 2017BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of ResponsesSale242,236$14.53KForm 4
Jul 14, 2017BVF PARTNERS L P/IL & BIOTECHNOLOGY VALUE FUND L P & BIOTECHNOLOGY VALUE FUND II LP & BVF INVESTMENTS LLC & BVF INC/IL & LAMPERT MARK NSee Explanation of ResponsesSale3,993,637$239.62KForm 4
Jan 4, 2017TAEGER LESLIE MSVP Chief Financial OfficerBuy50,000$3.50KForm 4
Dec 16, 2016MILLER LLOYD I III10% OwnerSale38,967$1.56KForm 4
Dec 15, 2016MILLER LLOYD I III10% OwnerSale20,000$800Form 4
Aug 12, 2016MILLER LLOYD I III10% OwnerSale16,000$880Form 4
Aug 1, 2016MILLER LLOYD I III10% OwnerSale80,000$4.86KForm 4
Jun 8, 2016MILLER LLOYD I III10% OwnerSale14,000$1.12KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related